Positron has entered into an exclusive sales and marketing agent agreement with NuView Radiopharmaceuticals in which NuView will act as exclusive agent for Positron's brand. The announcement was made at the 2008 Society of Nuclear Medicine (SNM) meeting in New Orleans, June 14-18.
"We are looking forward to NuView rapidly expanding the recognition of our brand. Our SPECT system combined with the newly acquired Pharm-Assist from Dose Shield is a perfect combination to introduce a total solution to nuclear cardiologists," said Joe Oliverio, president of Positron. “Our introduction of a cost effective, dedicated cardiac PET unit, alternative into this market will offer cardiologists the opportunity to provide patients with a more accurate diagnosis, an opportunity to increase their revenues, save healthcare dollars and at the same time improve patient outcomes."
The Park City, Utah-based NuView will be displaying Positron's molecular imaging products, and debuting its next-generation PET scanner, at SNM this week.